Archive for category: BJUI Blog

Thank You To All Our 2020 Peer Reviewers

We would particularly like to thank the following individuals who are the top reviewers for the journal in 2020, all with ≥10 reviews

Nathan Lawrentschuk Sima Porten
Tobias Klatte Roderick van den Bergh
Sigrid Carlsson Stephan Madersbacher
Riccardo Autorino Niranjan Sathianathen
Matthew Roberts Yair Lotan
Alexander Cole Asif Muneer

We are extremely grateful to all our reviewers for their time and hard work during an incredibly difficult year

Aastha Abdollah, Firas Abel, E. Abouassaly, Robert
Abrams, Paul Abreu, Leonardo Acher, Peter Adolfsson, Jan
Adshead, James Ahdoot, Michael Ahlawat, Rajesh Ahlgren, Johan
Ahluwalia, Puneet Ahmad, Imran Ahmed, Hashim Ahmed, Kamran
Aho, Tev Ajayi, Leye Al Jaafari, Feras Alam, Ridwan
Albersen, Maarten Albertsen, Peter Alhasso, Ammar Alifrangis, Constantine
Allaway, Matthew Aloj, Luigi Alzweri, Laith Aminsharifi, Alireza
Anderson, Christopher Anderson, Mark Anderson, Paul Andolfi, Ciro
Antonelli, Jodi Apostolidis, Apostolos Armitage, James Arndt, Volker
Arora, Sohrab Arsov, Christian Ashrafi, Akbar Assimos, Dean
Averbeck, Marcio Aydin, Abdullatif Baack Kukreja, Janet Baard, Joyce
Babjuk, Marek Badlani, Gopal H. Bahnson, Robert Bajic, Petar
Bajpai, Minu Balasubramanian, Adithya Ball, Mark Bandini, Marco
Bangma, Chris Barber, Neil Barod, Ravi Barrett, Tristan
Baumgarten, Adam Beard, David Becerra, Maria Becher, Edgardo
Bedke, Jens Behre, Hermann Beisland, Christian Belenchon, Ines
Bell, Richard Berglund, Anders Betschart, Cornelia Bex, Axel
Bhandari, Mahendra Bhat, Seetharam Bhatt, Jaimin Bhatt, Nikita
Bhindi, Bimal Bianchi, Daniele Bianchi, Lorenzo Birkhäuser, Frédéric
Birkhäuser, Veronika Biyani, Chandra Bjartell, Anders Blackmur, James
Blazeby, Jane Blecher, Gideon Blick, Christopher Blok, Bertil
Bloom, Jonathan Boddy, Jane Bogaert, Guy Bokhorst, Leonard
Bolgeri, Marco Bolton, Damien Boone, Timothy Borkowska, Edyta
Bose, Pradeep Boström, Peter Bratt, Ola Brehmer, Marianne
Brewin, James Brewster, Simon Briganti, Alberto Bromage, Steve
Brooks, Nathan Brouwer, Oscar Brown, Christian Brown, Matthew
Bryan, Richard Bryant, Richard Budäus, Lars Buffi, Nicolò
Bukavina, Laura Bultitude, Matthew Burgu, Berk Burkhard, Fiona
Butler, Santino Butow, Phyllis Byrne, Fiona Cadeddu, Jeffrey
Cahill, Declan Cai, Tommaso Caldamone, Anthony Camilleri, Philip
Campbell, Jeffrey Campeau, Lysanne Campi, Riccardo Canda, Abdullah Erdem
Canning, Douglas Cantiello, Francesco Capitanio, Umberto Capogrosso, Paolo
Cardozo, Linda Carlo, Buonerba Caroppo, Ettore Castiglione, Fabio
Castro-Diaz, David Cathcart, Paul Celia, Antonio Cellek, Selim
Cerruto, Maria Angela Challacombe, Ben Chancellor, Michael Chander, Sarat
Chandra, Ashish Chandra, Lizzie Chandrasekar, Thenappan Chang, David
Chapin, Brian Chapple, Christopher Chatta, Gurkamal Checcucci, Enrico
Chee, Justin Cheung, Douglas Chew, Ben Chi, Thomas
Chin, Joseph Chin, Kwang Chin, Peter Chin, Stephen
Chow, Ken Christopher, Nim Chuang, Yao-Chi Chun, Felix
Chung, Doreen Chung, Eric Clark, Jack Clemens, J. Quentin
Cohen, Ronald Collins, Justin Colquhoun, Alexandra Compérat, Eva
Cone, Eugene Coode-Bate, Jack Cooper, Colin Corcoran, Niall
Corcos, Jacques Cosker, Thomas Costello, Anthony Cotterill, Nikki
Cox, Edward Crabb, Simon Cracco, Cecilia Cranston, David
Cresswell, Joanne Crockett, Matthew Cross, Brian Cruz, Célia
Cruz, Francisco Cui, Helen Culig, Zoran Cullen, Victoria
Cumberbatch, Marcus Cutress, Mark Cuypers, Maarten Cynk, Mark
Da Ros, Carlos Dabestani, Saeed Dahm, Philipp Dan, Woodcock
D’Andrea, David Daneshmand, Siamak Danila, Daniel Danuser, Hansjoerg
Darr, Christopher Dasgupta, Ranan Dauw, Casey Davies, Lucy
Davis, John De Giorgi, Ugo de la Taille, Alexandre De Meerleer, Gert
De Reijke, Theo M. De Win, Gunter Del Popolo, Giulio D’Elia, Carolina
Dell’Oglio, Paolo Delprado, Warick Denstedt, John Derweesh, Ithaar
Desai, Janak Desai, Mahesh Diamond, David Dinkelman-Smit, M.
Dmochowski, Roger Doizi, Steeve Donovan, Jenny Dragos, Laurian
Drake, Marcus Droupy, Stéphane Dudderidge, Tim Dukic, Ivo
Dundee, Philip Eapen, Renu Eardley, Ian Eastham, James
Eberli, Daniel Eddy, Ben Eden, Christopher Egawa, Shin
Egevad, Lars Ehdaie, Behfar Eichler, Martin Eisenberger, Mario
Eisner, Brian Elders, Andrew Eldred-Evans, David Elhage, Oussama
Ellis, Robert Elmamoun, Mamoun Elneil, Sohier Elsamra, Sammy
Elshal, Ahmed Elterman, Dean Emberton, Mark Engeler, Daniel
Enikeev, Dmitry Enting, Deborah Epstein, Jonathan Erickson, Andrew
Escudero, Lorena Eure, Gregg Everaert, Karel Everaerts, Wouter
Eversden, Elizabeth Eyre, David Falagario, Ugo Falcone, Marco
Faltas, Bishoy Feber, Andrew Fero, Katherine Ferro, Matteo
Ficarra, Vincenzo Fife, Kate Finazzi Agrò, Enrico Finch, William
Fletcher, Sean Fojecki, Grzegorz Friedlander, David Frydenberg, Mark
Furr, James Furrer, Marc G. Zaorsky, Nicholas Gacci, Mauro
Gadzhiev, Nariman Gadzinski, Adam Gakis, Georgios Galfano, Antonio
Gall, Zara Gallagher, Kevin Gallieni, Maurizio Gandaglia, Giorgio
Gao, Chuanyu Gearhart, John Geavlete, Petrisor Georgiades, Fanourios
Geurts, Nicolas Ghai, Sangeet Ghani, Khurshid Ghazi, Ahmed
Gianduzzo, Troy Giannantoni, Antonella Gietzmann, William Giganti, Francesco
Gilbert, James Gild, Philipp Giusti, Guido Gnanapragasam, Vincent
Goldenberg, Larry Goldman, Howard Goldsmith, Louise Golla, Vishnukamal
Gomes, Cristiano Gontero, Paulo Good, Daniel Goonewardene, Sanchia
Gordon, Stephen Gorin, Michael Graefen, Markus Granr, Aurelie
Gravas, Stavros Gregg, Justin Grilo, Nuno Groen, Jan
Gross, Oliver Gross, Tobias Grummet, Jeremy Gulati, Roman
Gurney, Howard Guru, Khurshid Guruli, Georgi Ha, Yun-Sok
Hackett, Geoff Hakenberg, Oliver Hakimi, A Ari Hamid, Rizwan
Hamm, Rebecca Han, Deok Hyun Han, Ping Handelsman, David
Hasan, Mudhar Hashad, Mohamed Mohie Eldin Hashimoto, Takeshi Hatakeyama, Shingo
Haug, Alexander Häuser, Lorine Hautmann, Richard E. Hayne, Dickon
Heck, Matthias Heer, Rakesh Hegarty, Paul K. Heidenreich, Axel
Heijnsdijk, Eveline Helfand, Brian Heller, Nick Hellstrom, Wayne
Henderson, John Hendry, Rob Henry, Ann Hensley, Patrick
Herkommer, Kathleen Hermanns, Thomas Herrmann, Thomas Hindley, Richard
Hofman, Michael Hollingsworth, John Holmberg, Lars Hosseini, Abolfazl
Houédé, Nadine Hounsome, Luke Hovens, Chris Howles, Sarah
Hu, Jim Hughes, Simon Hulson, Oliver Humphreys, Mitchell
Hung, Andrew Husmann, Douglas Hutel, Michael Hwang, Eu Chang
Igawa, Yasuhiko Ilg, Marcus Innos, Kaire Ishioka, Junichiro
Jambor, Ivan JC, Liao Johnson, Mark Johnston, Thomas
Jonasch, Eric Jones, James Joseph, Jean Joyce, Adrian
Jung, Helene Jung, Jae Hung Junker, Kerstin Kalejaiye, Ayo
Kamal, Wissam Kamat, Ashish Kamphuis, Guido Kaouk, Jihad
Kaplan, Steven Karakiewicz, Pierre Karam, Jose Karnes, R
Kasivisvanathan, Veeru Kassouf, Wassim Kastner, Christof Kates, Max
Kattan, Mike KAYA, ENGIN Kayes, Oliver Keam, Simon
Keanie, Julian Keeley, Frank Kekre, Nitin Keoghane, Stephen
Kessler, Thomas Khaki, Ali Khan, Muhammad Shamim Khetrapal, Pramit
Khochikar, Makarand Kim, Hyung Kim, Isaac Kimura, Shoji
Kirsch, Andrew J. Kishida, Takeshi Kiss, Bernhard Kitta, Takeya
Klein, Eric Klein, Robert Kliesch, Sabine Klotz, Laurence
Kneebone, Andrew Knight, Simon Knipper, Sophie Knoll, Thomas
Knudsen, Bodo Kobayashi, Takashi Kockelbergh, Roger KOGA, Fumitaka
Kondo, Tsunenori Konety, Badrinath Koo, Kyo Chul Korte, James
Kosmoliaptsis, Vasilis Kotb, Ahmed Kovac, Evan Kozomara, Marko
Krambeck, Amy Kramer, Mario Kretschmer, Alexander Kriegmair, Maximilian
Kroeger, Nils Krokidis, Miltos Kulkarni, Meghana Kulkarni, Sanjay
Kumar, Sunil Kumar, Vivekanandan Kundu, Bibhas Kuo, Hann-Chorng
Kurithof-de Julio, Marianna Kutikov, Alex Kwan, Edmond Laguna, Pilar
Laird, Alexander Lallas, Costas Lam, Thomas Lam, Wayne
Lamb, Alastair Lamb, Benjamin Landman, Jaime Langenhuijsen, Johan
Lantz, Anna Larcher, Alessandro Lascano, Danny Laurentino, Sandra
Le Roux, Pieter Lec, Patrick Lee, Eugene Lee, Wai Gin
Leiber, Christian Leitner, Lorenz Lenfant, Louis Lenis, Andrew
Leow, Jeffrey Leppert, John Lerner, Lori Leung, Steve
Levine, Larry Lewington, Andrew Leyh-Bannurah, Sami-Ramzi Liatsikos, Evangelos
Liau, Siong Lilja, Hans Liow, Elizabeth Lipkin, Michael
Lipshultz, Larry Liu, Jui-Ming Lo, Simon Loblaw, Andrew
Loeb, Stacy Lonergan, Peter Lopez, Francisco Lopez-Beltran, Antonio
Louie, Alexander Louie-Johnsun, Mark Love, Christopher Lovegrove, Catherine
Lucca, Ilaria Lughezzani, Giovanni Luiting, Henk Luk, Angus
Luo, Jun Luzzago, Stefano Ma, Runzhuo MacLennan, Sara
MacPherson, Ruth Madaan, Sanjeev Madersbacher, Helmut Magee, Diana
Mahal, Brandon Malde, Sachin Manecksha, Rustom Manley, Brandon
Mantica, Guglielmo Marchioni, Michele Margulis, Vitaly Mari, Andrea
Mariappan, Paramananthan Mariotti, Guilherme Mark, Stephen Marks, Leonard
Marra, Giancarlo Marshall, Ernie Martin, Richard Martini, Alberto
Masson-Lecomte, Alexandra Masterson, Timothy Matanhelia, Mudit Matin, Surena
Matsumoto, Kazuhiro Mattei, Agostino Maurer, Tobias Mazhar, Danish
Mazzone, Elio McCaig, Fiona McGrath, John Mcintosh, lachlan
McNeill, Alan Mehan, Nicholas Mehnert, Ulrich Mehrazin, Reza
Meijer, Richard Mejean, Arnaud Mendichovszky, Iosif Meng, Maxwell
Menogue, Stuart Menon, Mani Merseburger, Axel Mertens, Laura
Meyer, Christian Miah, Saiful Michel, Martin Michels, Lars
Miernik, Arkadiusz Millar, Jeremy Miller, Eric Miller, Nipor
Mills, Ian Minhas, Suks Mir, Maria Mistretta, Francesco
Mitchell, Catherine Mitchell, Tom Mitin, Timur Mitra, Anirban
Moch, Holger Molden-Hauer, Tristan Molina-Garrido, Maria-Jose Monastyrskaya, Katia
Monn, M Francesca Montorsi, Francesco Moon, Daniel Moore, Caroline
Moore, Katherine Mordasini, Livio Moretti, Kim Morita, Masashi
Moschini, Marco Moschovas, Marcio Mossanen, Matthew Mostafid, Hugh
Muhitch, Jason Mühlstädt, Sandra Muir, Gordon Mukhopadhyay, Subhankar
Mulders, Peter Mumtaz, Faiz Mundy, Anthony Murphy, Declan
Murray, Julia Murray, Katie Murtola, Teemu Musco, Stefania
Mushtaq, Imran Mynbaev, Ospan Nabi, Ghulam Nabi, Junaid
Nair, Rajesh Namdarian, Benjamin Narayan, Vikram Nathan, Senthil
Neal, Naomi Necchi, Andrea Nelson, Adam Netsch, Christopher
Neumeier, Vera Neves, Joana Nguyen, David-Dan Nguyen, Hao
Nichol, David Nickel, J. Curtis Nicol, David Nieboer, Daan
Nieto, Yago Nobrega, Richard Nonomura, Norio Nordhoff, Verena
Nottingham, Charles Nyame, Yaw Nzenza, Tatenda Oades, Grenville
O’Brien, Tim O’Brien, Timothy O’Connor, Kevin Oddens, Jorg
Oh, William Olsburgh, Jonathon Omer, Altan Ong, Wee
Osses, Daniël Osther, Palle O’Sullivan, Richard Oudard, Stéphane
Ouzaid, Idir Paciotti, Marco Page, Toby Pal, Sumanta
Paller, Channing Panebianco, Valeria Panicker, Jalesh Pannek, Jürgen
Pantuck, Allan Pariser, Joseph Parker, Chris Parnham, Arie
Partin, Alan Pasquier, David Patel, Hiten Patel, Keval
Patel, Manish Patel, Parth Patel, Uday Patel, Vipul
Patil, Vishal Patki, Prasad Patterson, Jake Pavlovich, Christian
Payne, Steve Pearce, Ian Pearle, Margaret Pecoraro, Angela
Penzkofer, Tobias Perera, Marlon Perez Fentes, Daniel Pérez, Daniel
Peters, Craig Peters, Inga Peters, Max Petros, Firas
Pettaway, Curtis Peyronnet, Benoit Pfail, John Pfister, David
Phé, Véronique Philip, Stuart Pierorazio, Phillip Ploumidis, Achilles
Pokorny, Morgan Pontari, Mike Pook, David Popert, Richard
Porcaro, Antonio Porpiglia, Francesco Porter, James Portis, Andrew
Poulsen, Mads Pradere, Benjamin Preminger, Glenn Presicce, Fabrizio
Preston, Mark Proietti, Silvia Protheroe, Andrew Pryor, David
Quarrier, Scott Radtke, Jan Philipp Ragab, Mostafa Rai, Bhavan
Raison, Nicholas Rajan, Prabhakar Rajan, Probhakaran Rakauskas, Arnas
Ralph, David Ramakrishnan, Venkat Ramasamy, Ranjith Ranasinghe, Weranja
Rane, Abhay Rannikko, Antti Rashid, Aso Omer Rashid, Prem
Rassweiler, Jens Rastinehad, Ardeshir Ratan, Hari Ratliff, Timothy
Rawal, Sudhir Razvi, Hassan Rees, Rowland Reeves, Fairleigh
Rehder, Peter Reisman, Yacov Reiter, Robert Remzi, Mesut
Reynard, John Richenberg, Jonathan Rider, Jennifer Rieken, Malte
Riggs, Stephen Rimmer, Yvonne Rink, Michael Roberts, William
Robinson, Brian Robinson, Dudley Robson, Craig Rocco, Bernardo
Rochester, Mark Roehrborn, Claus Rogers, Craig Roghmann, Florian
Rolevich, Alexander Romero Otero, Javier Rosario, Derek Rosier, Peter
Ross, Ashley Rossi, Sabrina Rottenberg, Giles Rovito, Michael
Rowe, Courtney Ruiz-Castañe, Eduardo Rukin, Nicholas Russell, Neil
Russo, Giorgio Ivan Russo, Paul Sabnis, Ravindra Sadeghi, Ramin
Sadeghi-Nejad, Hossein Saeb-Parsy, Kasra Sahai, Arun Salami, Simpa
Salmon, Jonathan Salonia, Andrea Sammon, Jesse Sanchez-Salas, Rafael
Sangster, Philippa Sansone, Andrea Sarma, Aruna Satasivam, Prassannah
Satkunasivam, Raj Savovic, Jelena Schagdarsurengin, Undraga Schalken, Jack
Schartau, Patricia Scheiner, David Schenk, Jeannette Schmitz-Dräger, Bernd
Schneider, Florian Schneider, Marc Schurch, Brigitte Scriven, Sharon
Seisen, Thomas Sengupta, Shomik Sethi, Kapil Sethia, Krishna
Sfakianos, John Shabbir, Majed Shabbir, Majid Shah, Amishi
Shapiro, Daniel Sharma, Gyanendra Shaw, Greg Sheinfeld, Joel
Shi, Zhongjie Shiradkar, Rakesh Shoag, Jonathan Shoji, Sunao
Siddiqui, M Sievert, Karl-Dietrich Singla, Nirmish Siva, Shankar
Skipworth, Richard Skolarus, Ted Smith, Angela Smith, Phillip
Smyth, Lisa Soares, Ricardo Soave, Armin Soloway, Mark
Somani, Bhaskar Sonn, Geoffrey Sood, Akshay Soomro, Naeem
Sooriakumaran, Prasanna Soria, Francesco Sotelo, Rene Speakman, Mark
Speakman, MJ Spiess, Phillippe Sprenkle, Preston Srinivasan, Arun
Sripathi, Venkat Sriprasad, Seshadri Staehler, Michael Stai, Bethany
Stamatiou, Konstantinos Stark, Dan Stattin, Pär Stenzl, Arnulf
Steuber, Thomas Steyerberg, Ewout Stillebroer, Alexander Stinesen Kollberg, Karin
Stish, Bradley Stockler, Martin Stoffel, John Stolzenburg, Jens-Uwe
Stone, Nelson Stratton, Kelly Strebel, Räto Stricker, Phillip
Sturch, Paul Suarez, Rodrigo Subramaniam, Ramnath Sullivan, Mark
Sur, Roger Taghizadeh, Arash Takeda, Toshikazu Tan, Hung-Jui
Tan, Wei Shen Tandogdu, Zafer Tang, Chad Teh, Jiasian
Tekgul, Serdar Teoh, Jeremy Terris, Martha K. Tewari, Ash
Thalmann, George Thiruchelvam, Nikesh Thomas, Charalampos Thomas, Johanna
Thomas, John Thomas, Kay Thomas, Raju Thompson, James
Thompson, Peter Thompson, Robert Thurairaja, Ramesh Tilki, Derya
Timilshina, Narhari Tiselius, Hans-Göran Todenhöfer, Tilman Toren, Paul
Torinic, Jure Tortolero, Leonardo Tosoian, Jeffrey Touijer, Karim
Tourinho-Barbosa, Rafael Tran, Ben Tran, Maxine Traxer, Olivier
Trenti, Emanuela Tubaro, Andrea Tully, Karl Turkbey, Baris
Turnbull, Arran Turney, Ben Tuthill, Mark Tyerman, Kay
Ukimura, Osamu Unwala, Darius Urkmez, Ahmet Ursprung, Stephan
Usher-Smith, Juliet Van der Aa, Frank van der Kwast, Theo van der Poel, Henk
Van Hemelrijck, Mieke van Koeveringe, Gommert van Leeuwen, Pim van Moorselaar, Jeroen
van Rhijn, Bas van Rij, Simon Vanharanta, Sakari Vasdev, Nikhil
Vasudev, Naveen Veal, Gareth Venderbos, Lionne Verrill, Clare
Vickers, Andrew Vince, Randy Wagenlehner, Florian Walter, Matthias
Walz, Jochen Ward, John Warren, Anne Washington III, Samuel
Watkin, Nick Watson, Graham Watson, William Weber, Manuel
Welk, Blayne Weston, Michael Wetherell, David Whitehead, David
Wibmer, Andreas Williams, Andrew Williams, James Williams, Michael
Williams, Stephen Willis, Susan Wilson, Steven Wischmann, T.
Wiseman, Oliver Witjes, Fred Witjes, J. Wöllner, Jens
Wong, Lih-Ming Woo, Henry Wood, Dan Worst, Thomas
Wylie, Kevan Wysock, James Xylinas, Evanguelos Yamada, Yasutaka
Yamamoto, Hide Yang, Bing Yang, Bob Yang, David
Yaxley, John Ye, Dingwei Yong, Cissy Young, Matthew
Young, Robin Zainal Abidin, Zainal Adwin Zakri, Rhana Zaorsky, Nicholas
Zargar Shoshtari, Kamran Zargar, Homi Zhao, Lee Zhong, P.
Zhu, Gang Zigeuner, Richard Zimmern, Philippe Zlotta, Alexandre
Znaor, Ariana Zorn, Kevin

Residents’ podcast: MIMIC Study

Part of the BURST/BJUI Podcast Series

Mr Chuanyu Gao is a Core Surgical Trainee in KSS Deanery. He graduated from UCL Medical School and obtained his iBSc in Surgical Sciences before completing his Academic Foundation Years in East of England Foundation School. Chuanyu first became involved with BURST on the MIMIC Study as an international site coordinator and has been part of the BURST committee ever since. 

Factors associated with spontaneous stone passage in a contemporary cohort of patients presenting with acute ureteric colic: results from the Multi‐centre cohort study evaluating the role of Inflammatory Markers In patients presenting with acute ureteric Colic (MIMIC) study

Taimur T. Shah*†‡§, Chuanyu Gao*, Max Peters, Todd Manning**, Sophia Cashman*, Arjun Nambiar*, Marcus Cumberbatch*††, Ben Lamb*, Anthony Peacock‡‡, Marieke J. Van Son, Peter S. N. van Rossum, Robert Pickard§§, Paul Erotocritou¶¶, Daron Smith***, Veeru Kasivisvanathan*‡ and British Urology Researchers in Surgical Training (BURST) Collaborative MIMIC Study Group

 

*British Urology Researchers in Surgical Training (BURST), London, UK, Division of Surgery and Cancer, Imperial College London, Division of Surgery and Interventional Science, University College London, §Charing Cross Hospital, Imperial Health NHS Trust, London, UK, Department of Radiation Oncology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands, **Australian Young Urology Researchers Organisation (YURO), Heidelberg, Victoria, Australia, ††Academic Urology Unit, University of Shefeld, Shefeld, ‡‡Information Services Division, University College London (UCL), London, §§Department of Urology, Newcastle University, Newcastle, UK, ¶¶Department of Urology, Whittington Hospital, and ***Department of Urology, UCL Hospital, London, UK

 

Long live the BJUI

How time flies! It seems like only yesterday that I was appointed the 10th Editor‐in‐Chief of a 90‐year old major surgical journal. We assembled a dynamic team with a clear, modern vision and strategy. As we say goodbye, it is time to reflect fondly on our achievements.

The most read surgical journal on the web?

Of the many ways to measure this, one is the number of downloads of BJUI articles from our publisher Wiley Online Library. This has increased steadily every year, reaching 3 million downloads in 2019 alone. In addition to this we are regarded as pioneers of web‐based publishing and social media. The BJUI itself and its editorial team have a large, devoted following especially on Twitter. Our infographics, podcasts, picture quizzes, polls and videos were deliberately designed to grab an audience with limited time and short attention spans. The BJUI blogs have often been read more than the articles themselves, bringing immediacy, wider engagement and sensible debate. The most visited blog on the death of Nobel Laureate Tagore from prostatic enlargement was read nearly 110 000 times.

To increase the impact of the BJUI

Our impact factor has steadily increased since 2012, reaching the highest in its history and is as close to 5 as it ever has been. This has been achieved by decreasing the acceptance rate to 10% without any form of manipulation. This means that the BJUI papers are now “returnable” to any research excellence exercise of which many exist worldwide. As a clinician–scientist I could not accept anything else in academic circles. The BJUI is the only surgical journal to be rated in the Altmetric top 50 reaching a score of 1469 [1], compared to an average Altmetric score of 3. It is a testament to the hard work of our team above and beyond the impact factor. I suspect that with more fully open access journals such as the BJUI Compass , driven by Plan S, the importance of the impact factor as it now stands, may gradually diminish over time. We have also led on bringing innovation such as Artificial Intelligence [2] into our journal and making science accessible to a clinical audience through our “science made simple” section.

Quality without boundaries

While many of our papers come from the UK, USA and Australia, we have also published the best articles from Uganda, China, Japan, Iran, Korea, India, Pakistan and Peru. We are and remain a global journal, associated with 10 international societies. The NICE guidelines have been well cited over the last 3 years [3] as have the papers in our Trials section and the ever‐popular Guideline of Guidelines [4]. We have managed to co‐publish a number of high‐quality Cochrane reviews including the only one with a maximum AMSTAR score of 11 out of 11 comparing laparoscopic, robotic and open radical prostatectomy [5].

In this issue of the BJUI , we have published the protocol and curriculum development of the SIMULATE study – the world’s first and only multi‐centre randomised controlled trial of surgical simulation. What started as a BAUS study, expanded worldwide and recruited 1400 cases to see if simulation made better surgeons and improved patient outcomes [6].

The BJUI also brought innovative design from the fashion industry into academic publishing through the Glass magazine. As a parting gift, I therefore thought it fitting to publish a photograph of the courtyard of King’s College London where the SIMULATE trial first started. It was taken on a sunny day on my iPhone with no one in sight because of the pandemic. We have seen the viral crisis as an opportunity to learn from other nations and published a critical review to guide urological care for our colleagues, residents and patients [7].

I take this opportunity to thank a loyal group of friends at the BJUI Editorial offices, our trustees, the Associate and Consulting Editors, our wider editorial team of authors and reviewers and our publisher Wiley. I am proud to hand over the BJUI to my friend Freddie Hamdy in the best state of academic health and creativity.

Professor Dasgupta at his desk in his first month as BJUI Editor‐in‐Chief.

References

  1. Veale D, Miles S, Bramley S et al. Am I normal? A systematic review and construction of nomograms for flaccid/erect penis length and circumference. BJU Int 2015; 115: 978– 86
  2. Chen J, Remulla D, Nguyen JH et al. Current status of artificial intelligence applications in urology and their potential to influence clinical practice. BJU Int 2019; 124: 567– 77
  3. Guidance NICE. – Prostate cancer: diagnosis and management. BJU Int 2019; 124: 9– 26
  4. Sussman RD, Syan R, Brucker B. Guideline of guidelines: urinary incontinence in women. BJU Int 2020; 125: 638– 55
  5. Ilic D, Evans SM, Allan CA et al. Laparoscopic and robot‐assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review. BJU Int 2018; 121: 845– 53
  6. Aydin A, Ahmed K, Van Hemelrijck M et al. Simulation in Urological Training and Education (SIMULATE): Protocol and curriculum development of the first multicentre international randomized controlled trial assessing the transferability of simulation‐based surgical training. BJU Int 2020; 126: 202–11
  7. Puliatti S, Eissa A, Eissa R et al. COVID‐19 and urology: a comprehensive review of the literature. BJU Int 2020; 125: E7– E14

BJUI journal prizes

Every year the BJUI awards three prizes to trainee urologists who have played a significant role in contributing to the work published in the journal. The prizes go towards travel costs enabling the trainees to visit international conferences. In 2020, due to the coronavirus pandemic leading to the cancellation of many of these conferences, the usual prize-giving ceremonies have not taken place so here we are introducing you to the prize winners and their work. We hope they will be able to spend their prize money in 2021.

Global prize

This is awarded to authors who are trainees based anywhere in the world other than the Americas and Europe. Usually presented at the USANZ annual meeting. In 2020 the prize was awarded to Sho Uehara for his work on artificial intelligence in prostate cancer diagnosis.

Sho Uehara MD Ph.D Tokyo, Japan
Assistant professor, Department of Urology
Tokyo Medical and Dental University

Email: [email protected]

 

Sho Uehara received a Ph.D. from the graduate school of Tokyo Medical and Dental University, Tokyo, Japan, in 2018.  He is now working as a urologist and an assistant professor at the university hospital. His research interests include prostate cancer diagnostics, and utilization of machine learning for them.

Membership of academic societies:

JUA (The Japanese Urological Association), EAU (European Association of Urology) and AUA (American Urological Association)

 

Coffey-Krane prize

The Coffey-Krane prize is awarded to an author who is a trainee based in The Americas. Normally presented at the AUA annual conference. Dr Nathan Wong received this year’s award for his work on using machine learning to predict biochemical cancer recurrence following prostatectomy.

Dr Nathan Wong
Associate Professor
Westchester Medical Center and New York Medical College

Dr Nathan Wong is an assistant professor and associate program director in the Department of Urology at Westchester Medical Center and New York Medical College. He specializes in urologic oncology and robotics surgery. His main interests are in technology, clinical trials and surgical education. He completed a Society of Urologic Oncology fellowship at Memorial Sloan Kettering Cancer Center in New York City and urology residency at McMaster University in Hamilton, Ontario in Canada. 

 

John Blandy prize

This prize is for authors who are trainees based in Europe. Presented at the BAUS annual conference; the winner gives a presentation. This year the prize went to Nicholas Raison for his work on a RCT on cognitive training in robotic surgery.

Nicholas Raison is Vattikuti fellow at the MRC Centre for Transplantation and Mucosal Cell Biology, King’s College London and a Urology Specialist Registrar in the London Deanery.

Four seasons – Summer 2020’s top reviewer

Summer 2020’s top reviewer is Houston Thompson

This month, BJUI continues the Four Seasons Peer Reviewer Award recognising the hard work and dedication of our peer reviewers. Each quarter the Editor and Editorial Team select an individual peer reviewer whose reviews over the last 3 months have stood out for their quality and timeliness.

The Summer 2020 crown goes to Houston Thompson

R. Houston Thompson, MD, completed his Urology Residency at Mayo Clinic Rochester in 2007 followed by a Urologic Oncology Fellowship at Memorial Sloan-Kettering Cancer Center.  He is currently Professor of Urology at Mayo Clinic Rochester.  Dr. Thompson is involved in clinical and translational research in urologic oncology and has >200 peer-reviewed original articles.

Notable contributions to the literature include discovery that PD-1 and PD-L1 are aberrantly expressed in the microenvironment of renal cell carcinoma tumors, and thus represent attractive therapeutic targets.  Dr. Thompson is the recipient of the Donald C. Balfour Award for meritorious research from the Mayo Clinic and the Michael E. Burt Award for Clinical Excellence from Memorial Sloan-Kettering Cancer Center.

Coming out of lockdown safely – A view from China

How our lives have changed. Over two months ago we published a popular blog on the effect of COVID-19 on our surgical practice (https://www.bjuinternational.com/bjui-blog/covid-19-and-urology/). In many ways it informed us as to what to do during challenging times to keep our patients safe.

As we gradually take careful steps out of lockdown, our minds are focused on the most important of all words – SAFETY. 

While every nation will have differences and nuances, the principles of learning from each other, remain the same as they did when lockdowns started.

I am not surprised by new and ever changing information about the disease almost every day and see international collaboration as a powerful and positive tool in this situation.

With this in mind I requested our friends from Italy, China, Germany and New Zealand for their own perspectives.

Here are their thoughts for your reading pleasure.

Please feel free to insert your comments under the blog and share on social media.

Yours in friendship,
Prokar Dasgupta
Editor in Chief, BJUI

 

In China, after a 3-month period of lockdown, the whole country is looking forward to run back to the normal life.  The central government of China asked the local authorities lead the economic and daily life come out of lockdown gradually. Although the atmosphere of pandemic in China has become less tense, we are still paying fully attention on the prevention and detection of COVID-19. Below are the brief measures used in our hospital after the complete lockdown. It is important to note that the rules and guidelines varied from place to place, and adjusted according to the up-to-date situation.

  • On-site registration service in out-patient clinic is still prohibited. Outpatient clinic accepts online appointment only.
  • A temporary shelter clinic was built in February in my hospital. We are now still using the temporary shelter clinic to distinguish the suspicious infectors with other patients.
  • The flow of visitors in hospital is still under control. All the entrances are still monitoring people’s temperature and travelling history.
  • In the temporary shelter clinic, urologists have to wear examination gloves, surgical masks, and disposable hat and shoe cover in a single room for face to face consultation.
  • Negative complete blood count, chest CT, and oropharyngeal swab DNA tests are compulsory before inward admission for both patients and their accompanied relatives.

With the strict application of the protective measures, no in-ward patient or staff member had been infected by COVID-19 in my hospital. Although these measures add up a lot of works for my colleagues, I believe it is worthy as the threat of COVID-19 still exist.

Guohua Zeng, Di Gu and Wei Zhu
First Affiliated Hospital of Guangzhou Medical University, China

Coming out of lockdown safely – A view from Germany

How our lives have changed. Over two months ago we published a popular blog on the effect of COVID-19 on our surgical practice (https://www.bjuinternational.com/bjui-blog/covid-19-and-urology/). In many ways it informed us as to what to do during challenging times to keep our patients safe.

As we gradually take careful steps out of lockdown, our minds are focused on the most important of all words – SAFETY. 

While every nation will have differences and nuances, the principles of learning from each other, remain the same as they did when lockdowns started.

I am not surprised by new and ever changing information about the disease almost every day and see international collaboration as a powerful and positive tool in this situation.

With this in mind I requested our friends from Italy, China, Germany and New Zealand for their own perspectives.

Here are their thoughts for your reading pleasure.

Please feel free to insert your comments under the blog and share on social media.

Yours in friendship,
Prokar Dasgupta
Editor in Chief, BJUI

After having been hit by the pandemic just shortly after Italy, Germany experienced some early waves of COVID19  especially after some carnival festivities had spread the disease in some areas. The German government decided quite early to implement a strategy to deal with the outbreak. Initially the Ministry of health gave the restriction order to potspone evey plannable / elective surgery and hospital treatment, to „flatten the curve“  and thus avoid situations like in Italy, Spain or in the USA,  so that the Healthcare system would always allow for those in need to get an unflattered access to ventilation. This order had an immediate effect on urology practice throughout Germany. Some areas in Germany struggled with severe numbers of  COVID19, others were barely affected by the pandemic.

In our department, besides the usual hygiene measures like distancing, triage of patients by questionnaire and sending staff into „home office“ (the German term for working from home),  we immediately cancelled all benign cases, as well as low risk Prostate Cancer or small kidney cancer cases. Moreover, we additionally postponed those patients who would clinically fit into a higher risk category for suffering from a severe COVID19 course if they had acquired it, i.e patients with diabetes, severe COPD, older patients etc. also, initially surgeries with a higher likelihood for the necessity of postoperative ICU surveillance and treatment were postponed if possible.

After these initial tremendous cuts in caseload and patient numbers had more or less emptied the Intensive care units as well as hospital beds throughout Germany, it slowly became clearer that the quite solid Health System offered a lot more hospital beds as well as ICU / ventilation options, and that the general hygiene measures had apparently lead to a less intense outbreak in most parts of the country, some states and counties allowed to stepwise get back to a (reduced) normality – always under the caveat that epidemiological numbers stay low.

The German Government acted with a strong scientific support by one the world’s most respected coronavirus virologists, Prof Drosten of Charité Hospital Berlin, together with a team of the German Disease Control Institution („Robert Koch Institut“), and worked closely together with the state governors of the 16 German states, to share a common bundle of measures (still with nuances from state to state). Mass testing was made available quite early (yet, usually restricted to those with symptoms or contact persons). Currently, of 174,824, nationwide confirmed cases  7,917 people have died, making the death rate hit 4.5%.

Since a couple of days, we experience a stepwise way out of the lockdown in everyday life, with every state setting up slightly different measures; still, physical distancing and face masks are mandatory and shape the picture of everyday life. Since last week, restaurants and bars  are opening up again, and even the German Premier league went back to playing (with extremely strict measures like regular testing for every team member, as well as quarantine, but without any fans at the stadiums). Of note, regular testing for hospital staff is not required throughout Germany…

The way we work in our department has changed dramatically since the beginning of the pandemic. Our staff gatherings are restricted to only a few people, everybody wears masks, and is trying to keep their distance as much as possible, staff members who have office jobs like secretaries work from home. Urologic Surgery has resumed and is now performed back to almost normal case numbers; robotic cases have resumed to 100%, now performing 10 RARPs per day again. The waiting lists are long enough to cope with the otherwise probably reduced demand (due to a lack of biopsies, or outpatient urology consults resulting in referrals). There are still no visitors allowed, our hospital still has a separated entrance gateway for an initial triage, we send patients home sooner than we used to (for various reasons, patients usually stayed as inpatient for a week after surgery).

A recent survey of the German Working Group on Laparoscopic and Robotic Surgery of the German Society of Urology, amongst the busiest minimally invasive departments in Germany, reflected the situation of a quite colourful picture of minimally invasive Urology during the pandemic; it ranged from departments that are still barely functionally operating to hospitals with little or no restrictions in numbers. In some departments, parts of the wards were closed, and urologists were taking care of COVID 19 wards instead. The huge variety of responses reflects the differences in epidemiological impact in the 16 states of Germany – resulting in different restriction order patterns by the governments and county authorities. The results of our survey are currently put together and are soon to be published.

Dr. Christian Wagner , FEBU
Head of Robotic Urology, St. Antonius Hospital Gronau , Germany

 

Coming out of lockdown safely – A view from New Zealand

How our lives have changed. Over two months ago we published a popular blog on the effect of COVID-19 on our surgical practice (https://www.bjuinternational.com/bjui-blog/covid-19-and-urology/). In many ways it informed us as to what to do during challenging times to keep our patients safe.

As we gradually take careful steps out of lockdown, our minds are focused on the most important of all words – SAFETY. 

While every nation will have differences and nuances, the principles of learning from each other, remain the same as they did when lockdowns started.

I am not surprised by new and ever changing information about the disease almost every day and see international collaboration as a powerful and positive tool in this situation.

With this in mind I requested our friends from Italy, China, Germany and New Zealand for their own perspectives.

Here are their thoughts for your reading pleasure.

Please feel free to insert your comments under the blog and share on social media.

Yours in friendship,
Prokar Dasgupta
Editor in Chief, BJUI

It is hard to believe that 9 weeks ago as USANZ President the ASM was cancelled, due to the impending wave that was the Covid-19 global pandemic. Health and safety, reputation and finances were considered, in that order. USANZ 2020 ASM was the first major medical conference cancelled – others followed lockstep. There was no blueprint for this global black-swan event!

On our return to New Zealand an island country of 5 million, where 60% of health care is delivered via the public health “free for all” system, the remainder in the private sector. Our visionary Prime Minister, Jacinda Ardern initiated a “go-hard go-early” level 4 lockdown with only essential services open – elimination was the goal.

We were all un-prepared, and it lasted 5 weeks. A surgical pause in both health sectors allowed planning, preparation and training in PPE for the disease surge that did not arrive. We zoomed in our pyjamas and made sure we were free for the 1pm daily national television briefings featuring Jacinda Ardern and Ashley Bloomfield, DG of health, who has achieved cult status, and now features on a range of t-shirts. Cell phone tracking data indicated over 90% reduction in movement. Our “team of 5 million” has been a large part of the evolving success story. Elimination was possible, is possible and was confirmed! During this time manual contact tracing was expanded, testing snowballed, and Covid cases fell to zero.

During level 4 we undertook only non-deferrable surgical cases, with case definitions agreed by all specialties. We lost only 10% of our theatre volumes. OPD were completed by phone or video, and only patients that needed a procedure were seen face to face. Medically we have had no actual Covid cases in the surgical service, a handful of Covid patients in ICUs nationally. The majority of deaths did not reach ICU due to their age and co-morbidity.

We have now welcomed stepdown, level 2 with open arms, although concerned about a second wave of cases, however our unquestionable advantage of living in this unique country – our island fortress with a salt-water moat – sees us optimistic. We’re adjusting to sign in manually to all retail premises in light of no electronic tracing App and 80% of our businesses are open with the exception of bars, gatherings are restricted, and our hard borders remain.

Currently we enter the hospital via a staff entrance, with hand sanitiser but no masks. Patients are allowed 1 visitor only and have to sign in, use hand sanitiser and have restricted duration of visit. Normal surgical volumes have now resumed with no restrictions on the type of cases allowed.

We are advised to stay home if we have any respiratory symptoms, get a swab and cancel activity – no more kiwi grit or soldiering on! Patients are screened 7 days pre op by a phone call, delayed if international travel or a Covid contact within 14 days. A swab is only recommended if the patient is symptomatic, and if negative surgery can be completed. Patients are cancelled on the day of admission if they are unwell. Cancellations are now acceptable. A 20% operating theatre throughput reduction has been observed. We feel lucky, for now. From a USANZ perspective we are looking into innovative virtual meeting formats along with cancelling or postponing all face to face meetings.

Our international borders remain hard with a 14-day voluntary lockdown for all incoming. This will be in place until a successful vaccine is available. We accept international isolation will be in place for a while and hope to enjoy this pause, while implementing any useful learned strategies. We are proud of our inspirational leader, intelligent government and unprecedented international success – at least up until now. We wait, watch, listen and hold our breath… remember we are all in this together!

Stephen Mark, USANZ President

© 2020 BJU International. All Rights Reserved.